CN112370493A - Traditional Chinese medicine pill for treating ascites due to cirrhosis - Google Patents

Traditional Chinese medicine pill for treating ascites due to cirrhosis Download PDF

Info

Publication number
CN112370493A
CN112370493A CN202110025349.0A CN202110025349A CN112370493A CN 112370493 A CN112370493 A CN 112370493A CN 202110025349 A CN202110025349 A CN 202110025349A CN 112370493 A CN112370493 A CN 112370493A
Authority
CN
China
Prior art keywords
parts
prepared
cirrhosis
traditional chinese
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110025349.0A
Other languages
Chinese (zh)
Inventor
李君平
刘繁荣
王晓斌
张敏
柳巧红
郭新建
惠桃
高慧
张晓梅
万敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yulin Traditional Chinese Medicine Hospital
Original Assignee
Yulin Traditional Chinese Medicine Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yulin Traditional Chinese Medicine Hospital filed Critical Yulin Traditional Chinese Medicine Hospital
Priority to CN202110025349.0A priority Critical patent/CN112370493A/en
Publication of CN112370493A publication Critical patent/CN112370493A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/638—Ligustrum, e.g. Chinese privet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536—Prunella or Brunella (selfheal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/808—Scrophularia (figwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Husbandry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the field of traditional Chinese medicine preparations, in particular to a traditional Chinese medicine pill for treating ascites due to cirrhosis, which is prepared from effective components and pharmaceutically acceptable auxiliary materials, wherein the effective components are prepared from the following raw materials in parts by weight: 20-30 parts of glossy privet fruit, 10-20 parts of prepared rehmannia root, 5-15 parts of barbed skullcap herb, 10-15 parts of figwort root, 10-15 parts of kelp, 5-10 parts of stiff silkworm, 10-15 parts of selfheal, 10-20 parts of seaweed, 10-20 parts of vinegar rhizoma corydalis, 10-15 parts of salvia miltiorrhiza, 5-20 parts of mulberry and 3-6 parts of raw liquorice. The invention has the effects of nourishing yin, activating blood, softening hardness, dissipating stagnation, soothing liver and protecting liver, can effectively treat ascites due to cirrhosis, and achieves the effects of relieving symptoms recently and recovering liver function at a long term.

Description

Traditional Chinese medicine pill for treating ascites due to cirrhosis
Technical Field
The invention relates to the field of traditional Chinese medicine preparations, in particular to a traditional Chinese medicine pill for treating ascites due to cirrhosis.
Background
Cirrhosis is a chronic, progressive and diffuse liver disease caused by different causes, and the compensatory stage of cirrhosis is mostly manifested as low-grade fever, hypodynamia, abdominal distension, anorexia and other digestive tract symptoms; in addition to the above symptoms, ascites, jaundice, anemia, bleeding tendency, varicose veins in the abdominal wall, etc. may also occur in the decompensated period. At present, no specific medicine for treating ascites due to cirrhosis exists at home and abroad, and although some prescriptions for treating liver diseases with the effects of soothing liver, regulating qi, softening hardness, dissipating stagnation and the like exist in the field of traditional Chinese medicines, the general treatment effect is not ideal.
Disclosure of Invention
In order to solve the problems, the invention provides a traditional Chinese medicine pill for treating ascites due to cirrhosis.
In order to achieve the purpose, the invention adopts the technical scheme that:
a traditional Chinese medicine pill for treating ascites due to cirrhosis is prepared from effective components and pharmaceutically acceptable auxiliary materials, wherein the effective components are prepared from the following raw materials in parts by weight:
20-30 parts of glossy privet fruit, 10-20 parts of prepared rehmannia root, 5-15 parts of barbed skullcap herb, 10-15 parts of figwort root, 10-15 parts of kelp, 5-10 parts of stiff silkworm, 10-15 parts of selfheal, 10-20 parts of seaweed, 10-20 parts of vinegar rhizoma corydalis, 10-15 parts of salvia miltiorrhiza, 5-20 parts of mulberry and 3-6 parts of raw liquorice.
Preferably, the effective components are prepared from the following raw materials in parts by weight:
20 parts of glossy privet fruit, 10 parts of prepared rehmannia root, 5 parts of barbed skullcap herb, 10 parts of figwort root, 10 parts of kelp, 5 parts of stiff silkworm, 10 parts of selfheal, 10 parts of seaweed, 10 parts of vinegar corydalis tuber, 10 parts of salvia miltiorrhiza, 5 parts of mulberry and 3 parts of raw liquorice.
Preferably, the effective components are prepared from the following raw materials in parts by weight:
30 parts of glossy privet fruit, 20 parts of prepared rehmannia root, 15 parts of barbed skullcap herb, 15 parts of figwort root, 15 parts of kelp, 10 parts of stiff silkworm, 15 parts of selfheal, 20 parts of seaweed, 20 parts of vinegar corydalis tuber, 15 parts of salvia miltiorrhiza, 20 parts of mulberry and 6 parts of raw liquorice.
Preferably, the effective components are prepared from the following raw materials in parts by weight:
25 parts of glossy privet fruit, 15 parts of prepared rehmannia root, 10 parts of barbed skullcap herb, 12.5 parts of figwort root, 12.5 parts of kelp, 7.5 parts of stiff silkworm, 12.5 parts of selfheal, 15 parts of seaweed, 15 parts of vinegar rhizoma corydalis, 12.5 parts of salvia miltiorrhiza, 12.5 parts of mulberry and 4.5 parts of raw liquorice.
Preferably, the effective components are prepared from the following raw materials in parts by weight:
25 parts of glossy privet fruit, 15 parts of prepared rehmannia root, 10 parts of barbed skullcap herb, 13 parts of figwort root, 13 parts of kelp, 8 parts of stiff silkworm, 13 parts of selfheal, 15 parts of seaweed, 15 parts of vinegar corydalis tuber, 13 parts of salvia miltiorrhiza, 12.5 parts of mulberry and 5 parts of raw liquorice.
Preferably, the effective components are prepared from the following raw materials in parts by weight:
25 parts of glossy privet fruit, 15 parts of prepared rehmannia root, 10 parts of barbed skullcap herb, 12 parts of figwort root, 12 parts of kelp, 7 parts of stiff silkworm, 12 parts of selfheal, 15 parts of seaweed, 15 parts of vinegar corydalis tuber, 12 parts of salvia miltiorrhiza, 12 parts of mulberry and 4 parts of raw liquorice.
The invention has the effects of nourishing yin, activating blood, softening hardness, dissipating stagnation, soothing liver and protecting liver, can effectively treat ascites due to cirrhosis, and achieves the effects of relieving symptoms recently and recovering liver function at a long term.
Detailed Description
The present invention will be described in detail with reference to specific examples. The following examples will assist those skilled in the art in further understanding the invention, but are not intended to limit the invention in any way. It should be noted that variations and modifications can be made by persons skilled in the art without departing from the spirit of the invention. All falling within the scope of the present invention.
Example 1
A traditional Chinese medicine pill for treating ascites due to cirrhosis is prepared from effective components and pharmaceutically acceptable auxiliary materials, wherein the effective components are prepared from the following raw materials in parts by weight:
20 parts of glossy privet fruit, 10 parts of prepared rehmannia root, 5 parts of barbed skullcap herb, 10 parts of figwort root, 10 parts of kelp, 5 parts of stiff silkworm, 10 parts of selfheal, 10 parts of seaweed, 10 parts of vinegar corydalis tuber, 10 parts of salvia miltiorrhiza, 5 parts of mulberry and 3 parts of raw liquorice.
Example 2
A traditional Chinese medicine pill for treating ascites due to cirrhosis is prepared from effective components and pharmaceutically acceptable auxiliary materials, wherein the effective components are prepared from the following raw materials in parts by weight:
30 parts of glossy privet fruit, 20 parts of prepared rehmannia root, 15 parts of barbed skullcap herb, 15 parts of figwort root, 15 parts of kelp, 10 parts of stiff silkworm, 15 parts of selfheal, 20 parts of seaweed, 20 parts of vinegar corydalis tuber, 15 parts of salvia miltiorrhiza, 20 parts of mulberry and 6 parts of raw liquorice.
Example 3
A traditional Chinese medicine pill for treating ascites due to cirrhosis is prepared from effective components and pharmaceutically acceptable auxiliary materials, wherein the effective components are prepared from the following raw materials in parts by weight:
25 parts of glossy privet fruit, 15 parts of prepared rehmannia root, 10 parts of barbed skullcap herb, 12.5 parts of figwort root, 12.5 parts of kelp, 7.5 parts of stiff silkworm, 12.5 parts of selfheal, 15 parts of seaweed, 15 parts of vinegar rhizoma corydalis, 12.5 parts of salvia miltiorrhiza, 12.5 parts of mulberry and 4.5 parts of raw liquorice.
Example 4
A traditional Chinese medicine pill for treating ascites due to cirrhosis is prepared from effective components and pharmaceutically acceptable auxiliary materials, wherein the effective components are prepared from the following raw materials in parts by weight:
25 parts of glossy privet fruit, 15 parts of prepared rehmannia root, 10 parts of barbed skullcap herb, 13 parts of figwort root, 13 parts of kelp, 8 parts of stiff silkworm, 13 parts of selfheal, 15 parts of seaweed, 15 parts of vinegar corydalis tuber, 13 parts of salvia miltiorrhiza, 12.5 parts of mulberry and 5 parts of raw liquorice.
Example 5
A traditional Chinese medicine pill for treating ascites due to cirrhosis is prepared from effective components and pharmaceutically acceptable auxiliary materials, wherein the effective components are prepared from the following raw materials in parts by weight:
25 parts of glossy privet fruit, 15 parts of prepared rehmannia root, 10 parts of barbed skullcap herb, 12 parts of figwort root, 12 parts of kelp, 7 parts of stiff silkworm, 12 parts of selfheal, 15 parts of seaweed, 15 parts of vinegar corydalis tuber, 12 parts of salvia miltiorrhiza, 12 parts of mulberry and 4 parts of raw liquorice.
Clinical data
In order to further investigate the curative effect of the medicament, clinical trial research is carried out on patients suffering from liver cirrhosis, and all patients voluntarily receive treatment, so that the medicament has good response and no obvious toxic or side effect. Typical cases are as follows:
case 1: van one, female, 52 years old.
The result of the initial diagnosis: the patients have emaciation, lusterless complexion, abdominal distension and tympanites, mild edema of lower limbs, dark red tongue, yellow coating and wiry and thready pulse. Physical examination: the sclera is not yellow-stained, the abdominal circumference is 82cm, and the abdominal wall is varicose; the right lower costal region of the liver is not reached, the lower 8cm of the xiphoid process is, and the liver is hard; the abdomen of the left lower rib of the spleen 04 is tapped with moving voiced sounds; b ultrasonic examination shows that: ascites due to cirrhosis; the treatment is repeated 14 days after taking the traditional Chinese medicine pill in the example 1.
And (3) the result of the re-diagnosis: urinate obviously increased, abdominal distention obviously improved, abdominal circumference of 73cm, liver function normal, and ascites in B ultrasonic examination.
Case 2: zhangqi, male, 65 years old.
The result of the initial diagnosis: the inspection shows that the liver and the abdomen are swollen and have moving voice, sunken edema is formed from the lower part of knee joints to the upper part of ankle joints of both lower limbs, the tongue is dark, and the tongue coating is white and greasy; liver cirrhosis, gallbladder wall edema, splenomegaly, and abdominal dropsy can be seen through B-ultrasonic wave; abdominal distension, water in the abdomen, scanty urine, uncomfortable stool, pain in the hypochondrium, dark tongue, white and greasy tongue coating and wiry pulse; the treatment is repeated 14 days after taking the traditional Chinese medicine pill in the example 2.
And (3) the result of the re-diagnosis: patients mainly complain about the obvious improvement of abdominal distension, can accept the abdominal region, have flat abdomen and no edema in both lower limbs, and review of the type-B ultrasonic wave suggests cirrhosis, cholecystitis, splenomegaly and no obvious hydrops in the abdominal cavity and pelvic cavity.
Case 3: sunzhi, female, 72 years old.
The result of the initial diagnosis: abdominal fullness, abdominal distention, scanty urine, uncomfortable stool, pain in the hypochondrium, influence on respiration and diet, dark tongue, white and greasy tongue coating, and wiry pulse; b ultrasonic examination shows: cirrhosis, edema of the gallbladder wall, splenomegaly, and hydrops of the abdominal cavity; the treatment is repeated 14 days after taking the traditional Chinese medicine pill in the example 3.
And (3) the result of the re-diagnosis: patients complain about obviously improved abdominal distension, had good appetite, relatively flat abdomen and no edema in both lower limbs. And (3) rechecking the B ultrasonic mode: liver cirrhosis, cholecystitis, splenomegaly, and no obvious hydrops in abdominal cavity and pelvic cavity.
The foregoing description of specific embodiments of the present invention has been presented. It is to be understood that the present invention is not limited to the specific embodiments described above, and that various changes or modifications may be made by one skilled in the art within the scope of the appended claims without departing from the spirit of the invention. The embodiments and features of the embodiments of the present application may be combined with each other arbitrarily without conflict.

Claims (6)

1. A traditional Chinese medicine pill for treating ascites due to cirrhosis is prepared from effective components and pharmaceutically acceptable auxiliary materials, and is characterized in that: the active ingredients are prepared from the following raw materials in parts by weight:
20-30 parts of glossy privet fruit, 10-20 parts of prepared rehmannia root, 5-15 parts of barbed skullcap herb, 10-15 parts of figwort root, 10-15 parts of kelp, 5-10 parts of stiff silkworm, 10-15 parts of selfheal, 10-20 parts of seaweed, 10-20 parts of vinegar rhizoma corydalis, 10-15 parts of salvia miltiorrhiza, 5-20 parts of mulberry and 3-6 parts of raw liquorice.
2. The traditional Chinese medicine pill for treating ascites due to cirrhosis of liver of claim 1, wherein: the active ingredients are prepared from the following raw materials in parts by weight:
20 parts of glossy privet fruit, 10 parts of prepared rehmannia root, 5 parts of barbed skullcap herb, 10 parts of figwort root, 10 parts of kelp, 5 parts of stiff silkworm, 10 parts of selfheal, 10 parts of seaweed, 10 parts of vinegar corydalis tuber, 10 parts of salvia miltiorrhiza, 5 parts of mulberry and 3 parts of raw liquorice.
3. The traditional Chinese medicine pill for treating ascites due to cirrhosis of liver of claim 1, wherein: the active ingredients are prepared from the following raw materials in parts by weight:
30 parts of glossy privet fruit, 20 parts of prepared rehmannia root, 15 parts of barbed skullcap herb, 15 parts of figwort root, 15 parts of kelp, 10 parts of stiff silkworm, 15 parts of selfheal, 20 parts of seaweed, 20 parts of vinegar corydalis tuber, 15 parts of salvia miltiorrhiza, 20 parts of mulberry and 6 parts of raw liquorice.
4. The traditional Chinese medicine pill for treating ascites due to cirrhosis of liver of claim 1, wherein: the active ingredients are prepared from the following raw materials in parts by weight:
25 parts of glossy privet fruit, 15 parts of prepared rehmannia root, 10 parts of barbed skullcap herb, 12.5 parts of figwort root, 12.5 parts of kelp, 7.5 parts of stiff silkworm, 12.5 parts of selfheal, 15 parts of seaweed, 15 parts of vinegar rhizoma corydalis, 12.5 parts of salvia miltiorrhiza, 12.5 parts of mulberry and 4.5 parts of raw liquorice.
5. The traditional Chinese medicine pill for treating ascites due to cirrhosis of liver of claim 1, wherein: the active ingredients are prepared from the following raw materials in parts by weight:
25 parts of glossy privet fruit, 15 parts of prepared rehmannia root, 10 parts of barbed skullcap herb, 13 parts of figwort root, 13 parts of kelp, 8 parts of stiff silkworm, 13 parts of selfheal, 15 parts of seaweed, 15 parts of vinegar corydalis tuber, 13 parts of salvia miltiorrhiza, 12.5 parts of mulberry and 5 parts of raw liquorice.
6. The traditional Chinese medicine pill for treating ascites due to cirrhosis of liver of claim 1, wherein: the active ingredients are prepared from the following raw materials in parts by weight:
25 parts of glossy privet fruit, 15 parts of prepared rehmannia root, 10 parts of barbed skullcap herb, 12 parts of figwort root, 12 parts of kelp, 7 parts of stiff silkworm, 12 parts of selfheal, 15 parts of seaweed, 15 parts of vinegar corydalis tuber, 12 parts of salvia miltiorrhiza, 12 parts of mulberry and 4 parts of raw liquorice.
CN202110025349.0A 2021-01-08 2021-01-08 Traditional Chinese medicine pill for treating ascites due to cirrhosis Pending CN112370493A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110025349.0A CN112370493A (en) 2021-01-08 2021-01-08 Traditional Chinese medicine pill for treating ascites due to cirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110025349.0A CN112370493A (en) 2021-01-08 2021-01-08 Traditional Chinese medicine pill for treating ascites due to cirrhosis

Publications (1)

Publication Number Publication Date
CN112370493A true CN112370493A (en) 2021-02-19

Family

ID=74590003

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110025349.0A Pending CN112370493A (en) 2021-01-08 2021-01-08 Traditional Chinese medicine pill for treating ascites due to cirrhosis

Country Status (1)

Country Link
CN (1) CN112370493A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1165855A (en) * 1997-05-09 1997-11-26 赵洪山 Health liquor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1165855A (en) * 1997-05-09 1997-11-26 赵洪山 Health liquor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
崔秀瑜: "自拟消症腹水丸伍用西药治疗肝硬化腹水150例疗效观察 ", 《中国中西医结合急救杂志》 *

Similar Documents

Publication Publication Date Title
CN101181568B (en) Traditional chinese medicine preparation for curing osteoproliferation as well as arthrosis ache
CN102274464B (en) Chinese medicinal composition for treating chronic hepatitis, splenauxe and cirrhosis
CN108704108A (en) A kind of medicine pill for treating gout
CN102526640B (en) Pantoprazole sodium medicine compound and preparation technology thereof
CN103041145B (en) Traditional Chinese medicine composition for treating exogenous fever
CN112370493A (en) Traditional Chinese medicine pill for treating ascites due to cirrhosis
CN104547736A (en) Medicine for treating goiter
CN104784650A (en) Pharmaceutical preparation for clinical nursing of gastric ulcer
CN115607634B (en) Traditional Chinese medicine composition for preventing and treating hyperuricemia and gout and application thereof
CN110893206B (en) Externally applied medicine for treating rheumatic arthritis and preparation method thereof
CN1305509C (en) Medicine composition for treating labyrinthine syndrome and its preparation method
CN106309926A (en) Composition prepared from bee products and medical and edible dual-purpose food and used for treating gastritis and gastric ulcer
CN106421515B (en) Fenli capsule and preparation method and application thereof
CN104491556B (en) A kind of Chinese medicine composition for the treatment of caused by hepatic stagnation qi stagnation prostatic hyperplasia
CN116211973A (en) Traditional Chinese medicine decoction formula for treating fatty liver
CN105169199A (en) Traditional Chinese medicinal composition for treating functional dyspepsia with syndrome of liver-stomach disharmony
CN114306559A (en) Formula for treating gouty arthritis through oral administration and external washing
CN116474058A (en) Traditional Chinese medicine ointment for treating spleen enlargement
CN104491316A (en) Traditional Chinese medicine preparation for treating middle-warmer energy insufficiency type prostate hyperplasia
CN110652540A (en) Formula for treating food retention type diabetes and preparation method thereof
CN103768573B (en) A kind of spleen-stomach deficiency-cold eye for the treatment of is shed tears the Chinese medicine composition of pruritus
CN102698143B (en) Red/white peony root Chinese medicinal oral liquid for treating chronic hepatitis and preparation method
CN116983365A (en) Traditional Chinese medicine composition, preparation and application for treating chronic atrophic gastritis with deficiency of both qi and yin
CN117159667A (en) Traditional Chinese medicine decoction for treating ulcerative colitis with syndrome of liver qi stagnation and damp-heat
CN108904759A (en) A kind of Chinese medicine preparation and preparation method thereof for treating chronic gastritis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210219

RJ01 Rejection of invention patent application after publication